Short answer · Medically reviewed summary · Last updated: 2026-05-08
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Sub-Cortical Infarcts and Leukoencephalopathy) was first clinically defined in the 1970s and 1980s as a hereditary form of stroke, with the underlying NOTCH3 gene mutation identified in 1996. This discovery transformed the condition from a mysterious collection of symptoms into a precisely diagnosable genetic disorder, shifting the medical focus from managing symptoms to understanding the underlying vascular pathology. When was CADASIL first identified? While reports of familial stroke and dementia date back to the mid-20th century, the specific entity of CADASIL was characterized in the late 1970s and 1980s by researchers such as Dr.
What is the history of Cadasil (Cerebral Autosomal Dominant Arteriopathy With Sub-Cortical Infarcts And Leukoencephalopathy)?
History of Cadasil (Cerebral Autosomal Dominant Arteriopathy With Sub-Cortical Infarcts And Leukoencephalopathy): when and how it was discovered, and the milestones in research since, medically reviewed.
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Sub-Cortical Infarcts and Leukoencephalopathy) was first clinically defined in the 1970s and 1980s as a hereditary form of stroke, with the underlying NOTCH3 gene mutation identified in 1996. This discovery transformed the condition from a mysterious collection of symptoms into a precisely diagnosable genetic disorder, shifting the medical focus from managing symptoms to understanding the underlying vascular pathology.
When was CADASIL first identified?
While reports of familial stroke and dementia date back to the mid-20th century, the specific entity of CADASIL was characterized in the late 1970s and 1980s by researchers such as Dr. Marie-Germaine Bousser and Dr. Elisabeth Tournier-Lasserve. In 1993, the disorder was officially named, and by 1996, the genetic basis was pinpointed to mutations on chromosome 19p13, involving the NOTCH3 gene. This marked a pivotal moment in neurology, providing a clear genetic roadmap for diagnosis.
How has our understanding of CADASIL evolved?
Initially, CADASIL was often misdiagnosed as multiple sclerosis or sporadic, age-related vascular dementia. As magnetic resonance imaging (MRI) technology improved, clinicians began to recognize the specific pattern of white matter hyperintensities and temporal lobe involvement. Modern genetics have since revealed that CADASIL is likely underdiagnosed, as many individuals with milder genetic variants may not present with classic stroke symptoms until later in life.
What are the major milestones in the study of CADASIL?
- 1977: First report of familial multi-infarct dementia by Sourander and Walinder.
- 1993: The acronym CADASIL is coined, standardizing the clinical terminology.
- 1996: Discovery that the NOTCH3 gene is the causative factor in all cases.
- 2000s–Present: Use of skin biopsies to detect granular osmiophilic material (GOM) for diagnosis.
How has patient advocacy changed the landscape?
Historically, patients with CADASIL faced profound isolation due to the rarity of the diagnosis. Today, global communities—including the 57 members at DiseaseMaps.org—provide essential support, helping to bridge the gap between clinical research and patient experience. This collective voice has accelerated awareness, ensuring that neurologists are more likely to consider CADASIL in patients presenting with early-onset migraines or unexplained cognitive decline.
Next steps
- Consult a neurologist specializing in neurovascular genetics to discuss potential diagnostic testing.
- Connect with the 57 members of the DiseaseMaps.org CADASIL community for peer support and shared experiences.
- Keep updated on clinical trials focusing on NOTCH3 signaling pathways via NIH GARD.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.
References
- Orphanet: CADASIL (ORPHA:139)
- NIH GARD: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
- OMIM: NOTCH3 Gene (Entry #600276)
- PubMed: Classic reviews on the history and molecular pathogenesis of CADASIL
